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Introduction:  Although  arthroscopic  rotator  cuff repair  is  minimally  invasive,  there  is  still  considerable
postoperative  pain,  especially  during  the ﬁrst  48  hours.  The  present  study  assessed  the  short-term  efﬁcacy
and safety  of multimodal  analgesic  (MMA)  injection  associated  to corticosteroids  in arthroscopic  rotator
cuff tear  surgery.
Material  and method:  A single-center  prospective  randomized  study  included  50  patients  undergoing
arthroscopic  rotator  cuff  tear  surgery.  The  study  group  received  subacromial  injection  of  a mixture  of
morphine,  ropivacaine  and  methylprednisolone  associated  to intra-articular  injection  of  morphine  plus
methylprednisolone;  the  control  group  received  only  isotonic  saline.  All  patients  had  had  24 hours  self-
administered  morphine  associated  to  standard  analgesia.  Postoperative  data  were  recorded  at  30  minutes
and 1,  2, 4,  6,  12, 18  and  24  hours:  pain  intensity,  morphine  intake  and  side  effects,  and  also  time  to  ﬁrst
morphine  bolus  and  additional  analgesic  intake.  Constant,  ASES  and SST  functional  scores  were  recorded
at 3 months.
Results:  Postoperative  pain  was signiﬁcantly  less  intense  in  the  MMA  group  than  in  controls  at 30 min, H1,
H4,  H6,  H12,  H18  and  H24  (P  < 0.05).  A  rebound  at  D10  occurred  in  both  groups.  During  the  ﬁrst  24  hours,
MMA  signiﬁcantly  reduced  cumulative  resort  to  morphine  (P  < 0.05  at H1/2, P < 0.001  at H1–24).  Mean
time  to ﬁrst  bolus  was  signiﬁcantly  longer  in  the  MMA  group  (71.6  vs. 33  min;  P < 0.05).  The  rate  of
opioid-related  side  effects  was  similar  between  groups.  At last  follow-up,  functional  scores  were  similar
between  groups.  There  were  no  cases  of  infection  or  delayed  skin  healing.
Conclusion:  MMA  associated  to  corticosteroids  after  arthroscopic  rotator  cuff  tear  surgery  provided
immediate  beneﬁt  in  terms  of  analgesia  and  morphine  sparing,  without  apparent  risk  of  infection.  The
practice  is  presently  little  known  in  France  and  deserves  longer-term  assessment,  especially  as  regards
functional  rehabilitation  and  tendon  healing.
Level of evidence:  2.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Compared to traditional open surgery, arthroscopic rotator cuff
epair is increasingly performed due to its minimally invasive
ature, intra-articular diagnostic precision, simple postoperative
ourse and low morbidity [1–3]. While arthroscopic management
educes postoperative pain, rotator cuff repair still involves severe
ain, especially during the ﬁrst 48 hours [1,4–10], not only causing
onsiderable discomfort but also vitiating functional rehabilitation
nd lengthening hospital stay [9,11–13].
∗ Corresponding author. Tel.: +32 4 225 70 07.
E-mail address: perdreaua@hotmail.com (A. Perdreau).
http://dx.doi.org/10.1016/j.otsr.2015.09.006
877-0568/© 2015 Elsevier Masson SAS. All rights reserved.Patient-controlled analgesia (PCA) by intravenous opioid per-
fusion is the standard postoperative analgesic practice for most
orthopedic surgery, with the patient controlling dosage according
to pain [14]. The technique, however, has certain limitations in the
case of shoulder surgery: notably poor relief of mobilization pain,
and side effects including nausea and vomiting, pruritus, urinary
retention, sedation, hypoventilation and constipation [9,15].
In response to these drawbacks, multimodal analgesia (MMA)
has recently been recommended in postoperative pain manage-
ment [16–22]. The concept is based on associating 2 or more
substances or techniques, to improve the quality of analgesia and/or
reduce the rate of side effects. The different analgesic substances or
techniques act on different complementary sites, inducing additive
interactions or synergies.
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Mainly reported in knee and hip surgery, MMA  has proved effec-
ive in terms of pain management, reduced opioid side effects and
arly functional rehabilitation [23–25]. Unlike in prosthetic and
igamentous knee surgery [22,26–28], there have been very few
tudies of the efﬁcacy of MMA  protocols in arthroscopic rotator
uff repair. The 2012 studies in this context by the teams led by
ho [17] and Han [18] found local injection to be more effective
han PCA in pain management during the ﬁrst postoperative hours
ith associated reduction in resort to complementary analgesics
nd the corresponding side effects.
MMA  associated to corticosteroids proved effective and safe
n knee replacement [24,29,30], but has as yet been little studied
n arthroscopic rotator cuff repair [17]. The present study there-
ore sought to assess the short-term efﬁcacy and safety of MMA
ssociated to corticosteroids in arthroscopic treatment of full-body
otator cuff tear. The study hypothesis was that MMA  associated to
orticosteroids reduces postoperative pain and morphine intake.
. Material and method
.1. Material
A prospective randomized double-blind placebo-controlled
linical study was approved by the institutional review board; writ-
en consent forms were distributed to and signed by all patients.
Inclusion criteria comprised:
full-body supraspinatus tendon tear, with or without associated
infraspinatus or subscapularis tendon involvement;
frontal supraspinatus tendon retraction < grade 3 on the Patte
classiﬁcation [31];
muscular atrophy ≤ grade 2 on the Thomazeau classiﬁcation [32];
fatty inﬁltration ≤ grade 3 on the Goutallier classiﬁcation [33].
Exclusion criteria were:
ASA (American Society of Anesthesiologists) score ≥3;
history of drug abuse;
allergy to study drugs and/or local anesthetics;
severe neurologic or psychiatric disorder;
chronic corticosteroid treatment;
severe capsulitis.
Between December 2012 and February 2013, 54 patients under-
oing arthroscopic rotator cuff repair were enrolled. Two  (4%) were
xcluded during the study: one for psychological reasons and the
ther due to undesired interscalene block during a routine proce-
ure at the beginning of the study. Two others (4%) were lost to
ollow-up.
The series thus comprised 50 patients: 22 male (44%), 28 female
56%); mean age: 63 ± 8.89 years (range: 44–79 years). Mean
ollow-up was 4.5 ± 0.26 months (range: 5.1–3.4 months).
Ahead of each procedure, patients were randomized between
 groups by an independent agent. The study group (25 patients)
eceived postoperative multi-site injection of a mixture of 10 mg
orphine, 75 mg  ropivacaine and 120 mg  methylprednisolone
Fig. 1); the control group (25 patients) received only placebo injec-
ion of physiological saline without associated corticosteroids.
.2. Method.2.1. Preoperative assessment
Standard preoperative radiological assessment comprised
everity of osteoarthritis of the shoulder on the Hamada classiﬁ-
ation [34]. Tendon lesions were analyzed on contrast-enhancedFig. 1. Analgesic components of the multimodal analgesia.
CT-arthrography in 78% or cases or on MRI  in 22%. Assessment
criteria comprised:
• type of tear (partial or full-body);
• sagittal extension on the Patte classiﬁcation [31];
• degree of frontal retraction on the Patte and Bernageau classiﬁ-
cation [31];
• fatty inﬁltration on the Goutallier and Bernageau classiﬁcation
[33];
• muscular atrophy on the Thomazeau classiﬁcation [32].
Subscapularis lesions on preoperative imaging were adjusted
on arthroscopic assessment and classiﬁed on the new endoscopic
classiﬁcation of the French Arthroscopy Society (Société franc¸ aise
d’arthroscopie, 2011) [35].
2.2.2. Anesthesia
All surgery was performed under general anesthesia (thiopen-
tal and fentanyl), without complementary peripheral nerve block.
Rocuronium was injected to facilitate tracheal intubation. Anesthe-
sia was  maintained by sevoﬂurane and fentanyl.
2.2.3. Surgery
All procedures were performed by the same surgeon using a
standardized technique in both groups. Patients were semi-seated.
After complete arthroscopic shoulder joint assessment, tenotomy
of the long head of the biceps was  performed in most cases
of tenosynovitis, prerupture or SLAP type II. Tendon repair was
systematically preceded by subacromial decompression by bursec-
tomy and acromioplasty using a motorized burr (Table 1). The cuff
footprint was then freshened using the burr until the surface was
hemorrhagic. Depending on tear size, repair was  single or double
row, according to the department’s habits.
Ahead of surgery, patients were randomized between 2 groups
by an independent agent. An instrument nurse ensured prepara-
tion ahead of the surgeon’s arrival. Syringes were indistinguishable,
being of equal volume and visually resembling physiological saline.
At end of surgery, the study group received subacromial injection
of 10 ml  ropivacaine 75 mg  and half of a 5 ml  preparation of 10 mg
morphine and 120 mg  methylprednisolone; the other half was  then
injected into the shoulder joint (Fig. 2). The control group received
only physiological saline at the 2 sites.2.2.4. Analgesia
All patients received a PCA bolus of a mixture of morphine
(1 mg/ml, 1 mg  bolus, short 8 min  refractory period, max. dose
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Table  1
Comparison of associated procedures between groups.
Study group (%) Control group (%) P-value
LHB tenodesis 3 (12) 0 (0) N.S.
LHB  tenotomy 22 (88) 20 (80) N.S.
Acromioplasty 24 (96) 25 (100) N.S.
Acromioclavicular resection 2 (8) 2 (8) N.S.
LHB: long head of the biceps.
n protocol according to group.
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Table 2
Speciﬁc scores for nausea and vomiting, sedation and respiratory function.
Scores
Nausea and vomiting 0: no nausea
1: nausea
2: nausea with vomiting effort
3: nausea and vomiting
Sedation 0: awake
1: intermittently somnolent
2: somnolent most of the time, can be wakened by
verbal stimulation
3: somnolent, can be wakened by tactile stimulation
4: cannot be wakened
Respiration 0: regular unproblematic respiration, RR > 10/min
1: snoring and RR > 10/minFig. 2. Diagram of injectio
 mg/h) and droperidol (2.5 mg/50 mg  morphine) associated to
0 mg  iv nefopam (1 mg/ml  at 2 cc/h) for strictly 24 hours.
In case of persistent pain, relief analgesia comprising 1 g paracet-
mol, 100 mg  ketoprofen, 300 mg  paracetamol/10 mg  opium, and
0 mg  morphine was available according to level of discomfort and
eneral condition.
.2.5. Postoperative course
Discharge was generally within 48 hours, if pain was bearable
nd there were no complications.
Postoperative functional care comprised 1-month relative
mmobilization by elbow-to-body sling associated to immedi-
te pendulum exercises according to preoperative rehabilitation
dvice. Thereafter, rehabilitation was intensiﬁed by the physiother-
pist, following a speciﬁc program similar in all cases.
.2.6. Clinical assessment
Pain was assessed on a visual analog scale (VAS), with 0 repre-
enting absence of pain and 10 maximal pain. VASs were collected
n the eve of surgery (D1) and postoperatively at ½,  1, 2, 4, 6, 12,
8 and 24 hours, D10 and 1 and 3 months.
Cumulative PCA morphine intake was measured over 24 hours
t the same intervals as the VAS. The number of boli “requested
nd given” and “requested and not given” over a refractory period
ere noted. Time from extubation to ﬁrst morphine bolus given
as noted at admission to the post-anesthesia care unit.
Supplementary or relief analgesics were counted, type-by-type,
t D0, D1 and D10.
Morphine-related side effects such as nausea and vomiting or
espiratory or hemodynamic disorder were recorded over a 24-
our period. Nausea and vomiting, somnolence and respiratory
isorder were collected on speciﬁc scores (Table 2); hemodynamic
isorder was assessed on systolic and diastolic arterial pressure
nd heart rate. Complications such as superﬁcial or deep infection,2: irregular, obstruction, or RR < 10/min
RR: respiratory rate.
complex regional pain syndrome and delayed skin healing were
monitored.
2.2.7. Functional assessment
Functional assessment on Constant-Murley [36] and ASES
(American Shoulder and Elbow Surgeons) [37] scores and SST (Sim-
ple Shoulder Test) was  performed on the eve of surgery and at 3
months.
2.2.8. Statistical analysis
Statistical power, assessed on G*Power software, version 3.0.10
(Psychology Dept., Düsseldorf, Germany), determined a group size
of 21 to demonstrate a difference of 8 mg in total morphine intake
over 24 hours and achieve 0.80 power (  ˛ = 0.05;  ˇ = 0.20). The study
could thus detect a difference of 1.5 points on postoperative VAS
with 0.85 power.
Statistical analysis used the Statistical Package for the Social Sci-
ences, version 11.0 (SPSS Inc., Chicago, IL, USA). Univariate analysis
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 pain between groups. There was  rebound at D10 in both groups.
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Fig. 4. Comparison of mean time to ﬁrst morphine bolus between groups.Fig. 3. Comparison of pre- to postoperative change in mean
f qualitative variables used 2 or Fisher exact tests. Comparison
f continuous variables between 2 independent or matched groups
sed respectively the Mann-Whitney U or Wilcoxon ranks test.
. Results
.1. Demographic and lesion data
There were no signiﬁcant intergroup differences for gender,
ody-mass index, onset-to-surgery time, diabetes, smoking, trau-
atic etiology or work accident or occupational disease. However,
he study group was signiﬁcantly younger (Table 3).
Tendinous and osteoarticular lesion characteristics were similar
etween groups (Table 4). However, Patte grade 3 supraspinatus
endon retraction was signiﬁcantly more frequent in the control
roup.
.2. Pain
Mean early postoperative VAS scores at ½, 1, 2, 4, 6, 12, 18 and
4 hours were respectively 2.6, 2.8, 3.5, 2.7, 2.1, 1.5, 1.3 and 1.0 in
he study group and 4.1, 4.8, 4.0, 3.8, 3.5, 2.9, 2.4 and 2.3 in the
ontrol group, with signiﬁcantly lower scores at ½, 1, 4, 6, 12, 18
nd 24 hours in the study group (Fig. 3). There were no signiﬁcant
ntergroup differences in mean VAS preoperatively (D1) or at D10,
1 or M3  (study group: respectively 6, 4.5, 2.8 and 2.6; control
roup: 6, 5.2, 2.9 and 2.1).
Analysis of pain over time showed a common trend between
roups, with rebound at D10.
The only signiﬁcant difference with respect to preoperative pain
igniﬁcantly lower pain at D10 in the study group: i.e., weaker
ebound with MMA  (Table 5).
.3. Morphine and additional analgesics
The mean time to ﬁrst morphine bolus was signiﬁcantly longer
n the study group: 71.6 ± 85 min, vs. 33 ± 47.7 min  (P < 0.05)
Fig. 4). At each time-point, cumulative morphine intake was  lower
n the study group: P < 0.05 at ½ h; P < 0,001 from 1 to 24 h (Fig. 5).
ver a 24-hour period, the number of boli given and refused by
he pump was signiﬁcantly greater in the control group: 14.7 ± 7.9
nd 8.4 ± 6.6, vs. 21.4 ± 6.8 and 11.6 ± 6.0 (P < 0.005 and P < 0.05,
espectively) (Fig. 6).
However, the cumulative intake of non-steroidal anti-
nﬂammatory drugs at 24 h was signiﬁcantly greater in the
tudy group, whereas intake of other relief analgesics did not differFig. 5. Comparison of evolution of cumulative morphine dose at 24 hours between
groups.
between groups at 12 or 24 h or D10 (Fig. 7). This may be due to
reduced anti-inﬂammatory action of injected corticosteroids.
3.4. Side effects of analgesia and complications
Over a 24-hour period, there were no signiﬁcant intergroup
differences in systolic and diastolic blood pressure, heart rate or
urinary retention. Likewise, in-hospital scores for sedation, respi-
ratory function and nausea and vomiting did not differ between
groups (Table 6).
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Table  3
Comparison of sociodemographic data at inclusion.
Study group (n = 25) Control group (n = 25) P-value
Mean age (years ± SD) 60.6 ± 8.8 65.4 ± 8.7 0.046
Sex  ratio (M/F) 11/14 11/14 N.S.
Laterality (right/left) 14/11 17/8 N.S.
Mean  height (cm ± SD) 170 ± 0.1 160 ± 0.1 N.S.
Mean  weight (kg ± SD) 74.5 ± 17.1 73.8 ± 11.9 N.S.
BMI  (kg/m2 ± SD) 27.2 ± 5.5 27.6 ± 4.5 N.S.
Time  to surgery (months ± SD) 31.6 ± 56.4 14.5 ± 34.8 N.S.
Diabetes (%) 2 (8) 5 (20) N.S.
Smoker  (%) 6 (24) 4 (16) N.S.
Trauma (%) 7 (28) 8 (32) N.S.
WA/OD  (%) 4 (16) 2 (8) N.S.
BMI: body-mass index; WA/OD: work accident/occupational disease.
Table 4
Comparison of tendon and osteoarticular lesions at inclusion.
Study group (%) Control group (%) P-value
Frontal SSP retraction according to Patte
Grade 1 18 (72) 14 (56) 0.0423
Grade 2 7 (28) 5 (20)
Grade 3 0 (0) 6 (24)
Type of SSC lesion according to SFA
Type I 3 (25) 1 (5.9) N.S.
Type  II 3 (25) 5 (29.4)
Type III 2 (16.7) 2 (11.8)
Type IV 4 (33.3) 9 (52.9)
Segmental topography according to Patte
Segment 3 7 (28) 5 (20) N.S.
Segments 3 and 1 12 (48) 17 (68)
Segment 4 or 5 6 (24) 3 (12)
Fatty degeneration according to Goutallier
SSP
Grade 0 8 (32) 8 (32) N.S.
Grade  1 11 (44) 7 (28)
Grade 2 6 (24) 10 (40)
ISP
Grade 0 24 (96) 21 (84) N.S.
Grade  1 1 (4) 2 (8)
Grade 2 0 (0) 2 (8)
SSC
Grade 0 18 (72) 16 (64) N.S.
Grade  1 7 (28) 7 (28)
Grade 2 0 (0) 2 (8)
Muscular atrophy according to Thomazeau
SSP
Grade 1 20 (80) 19 (76) N.S.
Grade  2 5 (20) 6 (24
ISP
Grade 1 22 (88) 19 (76) N.S.
Grade  2 3 (12) 6 (24)
SSC
Grade 1 24 (96) 23 (92) N.S.
Grade  2 1 (4) 2 (8)
Tendon cleavage (yes/no)
SSP 2 (8)/23 (92) 2 (8)/23 (92) N.S.
ISP  2 (8)/23 (92) 1 (4)/24 (96) N.S.
Hamada
Grade  1 21 (84) 19 (76) N.S.
Grade  2 4 (16) 6 (24)
SFA: Société franc¸ aise d’arthroscopie; SSP: supraspinatus tendon; ISP: infraspinatus tendon; SSC: subscapularis tendon.
Table 5
Comparison of rebound of pain at D10 and mean preoperative pain (D1) between groups.
Preoperative VAS (D1) Postoperative VAS (D10) P-value
Study group 6.0 ± 2.0 4.5 ± 2.1 0.022
Control  group 6.0 ± 1.9 5.2 ± 2.3 0.054
VAS: visual analog scale.
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Table 6
Comparison of vital parameters and postoperative complications between groups.
Study group Control group P-value
SAP (mmHg ± DS) 134 ± 20.3 137.8 ± 16.4 N.S.
DAP  (mmHg ± DS) 75.2 ± 10.4 78.3 ± 7.7 N.S.
HR  (bat/min ± DS) 79.2 ± 13.6 77 ± 8.8 N.S.
Sedation score
0 7 (28%) 8 (32%) N.S.
1  17 (68%) 15 (60%)
2  1 (4%) 2 (8%)
Respiratory score
0 21 (84%) 21 (84%) N.S.
1  1 (4%) 2 (8%)
2  3 (12%) 2 (8%)
PONV score
0  20 (80%) 22 (88%) N.S.
1  5 (20%) 2 (8%)
2  0 (0%) 1 (4%)
Complications
Urinary retention 0 (0 %) 2 (8 %) N.S.
Infection 0 (0 %) 0 (0 %) N.S.
CRPS  4 (16%) 1 (4%) N.S.
Fall  1 (4%) 1 (4%) N.S.
Delayed skin healing 0 (0%) 0 (0%) N.S.
SAP: systolic arterial pressure; DAP: diastolic arterial pressure; HR: heart rate; PONV: po
Fig. 6. Comparison of number of morphine boli accepted and refused in 24 hours
between groups.
F
w
c
little investigated in arthroscopic rotator cuff repair. Some reportsig. 7. Comparison of evolution of number of additional analgesics between groups.
There were no local complications such as infection or delayed
ound healing in patients receiving corticosteroid injection.
There were no cases of deep infection at the last (3 months)
linical follow-up. The rate of accidental falls was similar betweenstoperative nausea and vomiting; CRPS: complex regional pain syndrome.
groups. Although complex regional pain syndrome was more fre-
quent in the study group, the difference was not signiﬁcant.
3.5. Clinical scores
At a mean 4.5-month follow-up, the clinical Constant, ASES and
SST scores were signiﬁcantly improved in both groups (Table 7),
but without signiﬁcant difference in global or item scores between
groups at last follow-up.
Ranges of motion were similar between groups at 1- and
3-month follow-up; only anterior elevation at 1 month was sig-
niﬁcantly better in the MMA  group (Table 8).
4. Discussion
The main results of the present study show that the proto-
col of MMA  plus corticosteroids signiﬁcantly improved pain and
morphine sparing over a 24-hour period, without additional com-
plications.
Conventional analgesia protocols, such as opioid PCA, local
injection and regional nerve block, are usually implemented to
control pain after arthroscopic rotator cuff repair. There have, how-
ever, been many reports of drawbacks in terms of side effects and
risk [9,15,18,38–41] and of reduced efﬁcacy in isolated application
[6,7,9,42,43]. Consequently, arthroscopic rotator cuff repair is often
associated with severe postoperative pain, especially during the
ﬁrst 48 hours [1,4–10].
The MMA  concept is based on combining analgesics of differ-
ent classes (opioids, non-steroidal anti-inﬂammatory drugs and
local anesthetics), injected locally in one or several sites and act-
ing simultaneously on pain pathways, with additive or synergic
effect, thereby allowing lower concentrations and less side effects.
The efﬁcacy and safety of MMA  is well established in knee replace-
ment surgery according to several authors [20–25], but remainsfound MMA  to be more effective than opioid PCA in terms of pain
control and cost [18,17], while others found isolated application
less effective than interscalene nerve block [16].
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Table  7
Comparison of pre- and postoperative clinical scores between groups.
Study group Control group
Preop Postop P-value Preop Postop P-value
Constant score
Pain 6.4 ± 2.1 11.8 ± 4.4 <0.001 6.5 ± 1.8 12.4 ± 3.3 <0.001
Activity 4.6 ± 2.0 8.7 ± 2.4 <0.001 5.3 ± 2.3 7.6 ± 9.4 <0.005
Work 8.7 ± 1.6 9.4 ± 1.5 N.S. 9.4 ± 1.3 9.7 ± 0.9 N.S.
RoM  32.0 ± 8.3 34.5 ± 9.2 N.S. 30.5 ± 8.6 34.8 ± 6.5 <0.05
Strength 7.0 ± 3.1 9.0 ± 4.1 <0.01 8.3 ± 5.0 9.2 ± 4.5 N.S.
Total  58.8 ± 12.9 72.7 ± 18.2 <0.01 59.9 ± 14.1 72.2 ± 14.4 <0.001
ASES
Pain  6.0 ± 2.0 2.6 ± 2.3 <0.001 6.0 ± 1.9 2.1 ± 2.6 <0.001
ADL  13.6 ± 5.5 25.9 ± 7.2 <0.001 15.0 ± 6.6 25.4 ± 5.7 <0.001
SSI  42.9 ± 16.2 80.2 ± 22.2 <0.001 45.2 ± 17.0 81.7 ± 20.1 <0.001
SST  4.5 ± 2.9 9.7 ± 3.7 <0.001 4.8 ± 2.8 8.6 ± 3.1 <0.001
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AoM: range of motion; ASES: American Shoulder and Elbow Surgeons; ADL: activiti
Preventive surgery site analgesia, with the advantage of reduc-
ng systemic side effects, is an attractive idea. Surgical trauma
ustained during rotator cuff repair alters nervous system reactivity
long two pathways:
peripheral system sensitization, lowering the afferent nociceptor
activation threshold;
central system sensitization, increasing spinal neuron excitation
[26].
Taken together, these contribute to painful postoperative hyper-
ensitivity, heightening response to noxious stimuli and lowering
he pain threshold in and around traumatized tissue [26]. Preven-
ive analgesia administered directly to the surgery site has been
hown to avoid central sensitization and improve postoperative
ain control [44]. In the present study, the analgesic cocktail com-
rised morphine, ropivacaine and methylprednisolone.
It is generally agreed that morphine’s analgesic action consists
n binding to central nervous system opiate receptors. However,
nee arthroscopy and animal studies [45–49] showed that periph-
ral and intra-articular administration of opioids induced powerful
nalgesia in situations of inﬂammation or stress, indicating the
xistence of speciﬁc intra-articular opioid receptors. Nevertheless,
solated subacromial and intra-articular morphine administration
rovided little alleviation of pain following arthroscopic shoulder
urgery [50,51].
Local anesthetic injection may, in addition to direct effects,
nhance postoperative analgesia by inhibiting neuroendocrine
esponses secondary to surgical stress [9,15,50]. Continuous
dministration by pain pump should, however, be avoided in
otator cuff repair, due to risk of chondrotoxicity [26,52–54]. Pro-
onged intra-articular administration of high-dose bupivacaine can
able 8
omparison of Constant range of motion scores between groups.
Study group Con
1-month postop
AE 6.7 5.6 
ABD  5.5 4.4 
ER  5.7 4.7 
IR  4.2 3.0 
3-month postop
AE 9.0 9.0 
ABD  9.0 9.0 
ER  8.4 9.0 
IR  8.1 7.9 
E: anterior elevation; ABD: abduction; ER: external rotation; IR: internal rotation.aily life; SSI: Shoulder Score Index; SST: Simple Shoulder Test.
cause chondrotoxicity, with severity depending on concentration
and duration [55]. Likewise, there are concerns relating to myotoxi-
city induced by subacromial analgesia [55,56]. However, the impact
of local anesthetics on rotator cuff muscle ﬁbers has not been
clearly elucidated. To get around the problem of chondrotoxicity, in
the present study ropivacaine was  mainly injected subacromially
rather than into the joint itself, with a single rather than contin-
uous injection [57]. Moreover, ropivacaine was  chosen because
its systemic side effects are milder than those of bupivacaine
[58].
The anti-inﬂammatory action of corticosteroids involves
phospholipase A2 inhibition, reducing the production of
pro-inﬂammatory derivatives of arachidonic acid such as
prostaglandins or leukotrienes [59]. Widely used in knee
replacement surgery, adding corticosteroids to MMA  improves
postoperative pain control and function (range of motion and
muscle force) and reduces morphine consumption and hospital
stay [24,25,29,30].
In arthroscopic shoulder surgery, only Cho et al. [17], recently
and for the ﬁrst time, studied the efﬁcacy of corticosteroids associ-
ated to MMA  in arthroscopic rotator cuff repair. Compared to PCA,
the MMA  group reported less immediate and short-term postop-
erative pain and had earlier passive functional rehabilitation using
a continuous passive motion device, as measured by time to recov-
ery of 120◦ anterior elevation and 30◦ external rotation. In contrast,
the present study assessed active functional rehabilitation on Con-
stant, ASES and SST scores at 3 months; although MMA  seemed not
to affect these scores, there was improvement in active anterior
elevation at 1 month in the MMA  group.
Intraoperative local corticosteroid injection, on the other hand,
is controversial, with concerns relating to infection, delayed heal-
ing and tendon tear. Armstrong and Dias [60] reported a correlation
trol group P-value
<0.05
N.S.
N.S.
N.S.
N.S.
N.S.
N.S.
N.S.
S atolog
b
o
t
o
t
t
a
c
p
r
m
n
m
h
c
a
t
2
t
g
O
t
t
b
t
o
r
f
h
e
r
b
r
o
s
t
t
(
a
l
r
t
a
5
i
r
a
a
d
t
D
c
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[344 A. Perdreau, T. Joudet / Orthopaedics & Traum
etween intraoperative intra-articular corticosteroid injection and
nset of septic arthritis following arthroscopic surgery. The infec-
ion rate was very low (0.42%), with 8 cases of septic arthritis out
f 4256 knee arthroscopies; although none could be attributed
o the corticosteroid injection, the authors concluded empirically
hat there was a strong association between cortisone injection
nd onset of septic arthritis. Regarding safety, several randomized
ontrolled prospective studies [24,25,29,30] showed that intra- or
eri-articular MMA  associated to corticosteroids did not increase
isk of infection, delayed healing or tendon tear after knee replace-
ent. In agreement with Cho et al. [17], the present study found
o cases of superﬁcial or deep infection or delayed healing at 3
onths’ follow-up, despite corticosteroid doses that were 3-fold
igher (120 mg  methylprednisolone).
The present results thus demonstrate that MMA  associated to
orticosteroids reduced not only immediate postoperative pain but
lso D10 rebound as compared to controls. This leads us to think
hat the clinical beneﬁt of this protocol persists beyond the ﬁrst
4 hours [17,18]. Compared to controls, morphine intake during
he ﬁrst 24 postoperative hours was signiﬁcantly lower in the MMA
roup, and the time to ﬁrst morphine bolus was signiﬁcantly longer.
n the other hand, there was no reduction in side effects related to
his reduced intake of analgesics. Postoperative nausea and vomi-
ing and anti-emetic intake differed little between groups. This may
e due to the preventive association of anti-emetics (droperidol)
o PCA morphine. The MMA  protocol had the further advantages
f technical simplicity, rapid implementation, and safety, without
equirement of patient supervision and education.
The study limitations comprise a short (3 months) clinical
ollow-up; a longer period, with a larger number of patients, would
ave enhanced validation and provided stronger proof of the inter-
st of MMA  in arthroscopic rotator cuff repair. Moreover, functional
ehabilitation and late side effects such as tendon tear could have
een assessed over a longer-term. Another limitation was that the
elative contribution of each class of injected analgesic in terms
f efﬁcacy and safety could not be determined. Finally, at end of
urgery, there was partial leakage of the injected mixture from
he skin incisions, although this seemed very slight compared to
he total volume administered. Extending injection to other sites
muscle layer, fat layer, subcutaneous tissue, suprascapular nerve),
s proposed by certain authors [16–18], might have reduced this
oss and boosted the action of MMA.  Gerber et al. [61,62] recently
eported that intramuscular injection of corticosteroids after rota-
or cuff tear delayed muscle cell degeneration by anabolic action,
lthough without regenerating the affected muscle.
. Conclusion
Multimodal analgesic injection associated to corticosteroids has
mmediate impact on pain and morphine sparing after arthroscopic
otator cuff repair, without apparent risk of infection. It is not
t present a known practice in France, and deserves longer-term
ssessment, especially as regards functional rehabilitation and ten-
on healing. The question arises as to its future role in day-surgery,
o improve patient comfort and reduce hospital stay.
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